Aptevo Therapeutics Inc. Annual Return On Equity in % from 2016 to 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Aptevo Therapeutics Inc. quarterly/annual Return On Equity history and growth rate from 2016 to 2023.
  • Aptevo Therapeutics Inc. Return On Equity for the quarter ending September 30, 2024 was -349 %, a 290% decline year-over-year.
  • Aptevo Therapeutics Inc. annual Return On Equity for 2023 was -105 %, a 266% decline from 2022.
  • Aptevo Therapeutics Inc. annual Return On Equity for 2022 was 63.1 %.
  • Aptevo Therapeutics Inc. annual Return On Equity for 2021 was -346 %, a 108% decline from 2020.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -105 -168 -266% Jan 1, 2023 Dec 31, 2023
2022 63.1 +409 Jan 1, 2022 Dec 31, 2022
2021 -346 -179 -108% Jan 1, 2021 Dec 31, 2021
2020 -167 +0.27 +0.16% Jan 1, 2020 Dec 31, 2020
2019 -167 -58.9 -54.5% Jan 1, 2019 Dec 31, 2019
2018 -108 -118 -1205% Jan 1, 2018 Dec 31, 2018
2017 9.78 +159 Jan 1, 2017 Dec 31, 2017
2016 -149 Jan 1, 2016 Dec 31, 2016
* An asterisk sign (*) next to the value indicates that the value is likely invalid.